Related Experiment Video
Updated: Nov 26, 2025
Author Spotlight: A Lightweight Drive Implant for Chronic Tetrode Recordings in Juvenile Mice
Published on: June 2, 2023
Chediak-Higashi syndrome: neurocognitive and behavioral data from infancy to adulthood after bone marrow
Aino Yliranta1, Jussi Mäkinen1
1Department of Neurology, Lapland Central Hospital, Rovaniemi, Finland.
Insights
Chediak-Higashi syndrome (CHS) is a rare disorder impacting neurological function. Early assessment is vital for intervention, as this case shows varied neurodevelopmental progression in young adults.
Area of Science:
- Genetics and rare diseases
- Neuroscience
- Immunology
Background:
- Chediak-Higashi syndrome (CHS) is a rare autosomal recessive disorder.
- It presents with immunodeficiency, partial albinism, and progressive neurological deterioration.
- Long-term neurodevelopmental outcomes in CHS survivors are not well-documented.
Observation:
- This study details the case of a young adult with CHS, tracking their development from infancy.
- The patient's records cover the period leading up to the initial signs of neurological decline.
- Notably, the patient exhibited high socioemotional adaptability without overt neuropsychiatric symptoms.
Findings:
- Early neuropsychological and neuropsychiatric profiling is essential for effective intervention strategies in CHS.
- Standard special education may not be suitable for children with CHS due to unique neurodevelopmental trajectories.
- The case highlights variability in the progression of neurological abnormalities in CHS.
Implications:
- Findings underscore the need for tailored educational and therapeutic approaches for CHS patients.
- Early identification of subtle neurological changes can guide personalized care plans.
- Further research into long-term neurocognitive outcomes in CHS is warranted to optimize patient management.
Abstract:
Chediak-Higashi syndrome (CHS) is a rare autosomal disorder characterized by immunodeficiency, albinism, and progressive neurologic abnormalities. While survivors of the childhood-onset disease are known to exhibit learning disabilities and neuropsychiatric disorders followed by middle-age dementia, we lack detailed data on the progression. We present the case of a young adult with records from infancy to the first signs of deterioration. An early neuropsychological and neuropsychiatric profiling is crucial to intervention selection as children with CHS may not benefit from regular special education. Our patient never showed neuropsychiatric symptoms but high levels of socioemotional adaptability.
